{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:33:39Z","timestamp":1792499619995,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MSD Animal Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The isoxazoline fluralaner is effective for prevention of <jats:italic>Babesia canis<\/jats:italic> transmission from infected <jats:italic>Dermacentor reticulatus<\/jats:italic> ticks to dogs for 84\u00a0days in a controlled environment. This study was designed to evaluate the effectiveness of fluralaner chewable tablets for sustained prevention of <jats:italic>B. canis<\/jats:italic> infection of dogs in endemic areas under natural conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In Europe, privately owned, clinically healthy pet dogs were enrolled and randomized either to receive fluralaner at 25\u201356\u00a0mg\/kg (Bravecto<jats:sup>\u00ae<\/jats:sup> chewable tablets) on days 0 and 84, or to remain untreated during the <jats:italic>D. reticulatus<\/jats:italic> season. Blood samples were collected to evaluate <jats:italic>B. canis<\/jats:italic> exposure: on days 0 and 21 (exposure before day 0), during the study and at the end of the tick season (dogs suspected of having become infected after day 0). Efficacy was determined by the percentage reduction in <jats:italic>B. canis<\/jats:italic> transmission risk based on the difference in <jats:italic>B. canis<\/jats:italic>-positive tests in fluralaner-treated dogs compared with untreated dogs. In addition, ticks collected at monthly intervals throughout the study were identified to species level and females tested for <jats:italic>B. canis<\/jats:italic> DNA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 152 dogs were enrolled in the study, although nine dogs were excluded because they tested positive for <jats:italic>B. canis<\/jats:italic> DNA or antibodies within 21\u00a0days after enrollment. During the study period, no fluralaner-treated dog became positive for <jats:italic>B. canis<\/jats:italic>, resulting in calculated efficacy of 100%. However, babesiosis infection was diagnosed in five untreated control dogs (Fisher\u2019s exact test, left-sided, <jats:italic>P<\/jats:italic>\u2009=\u20090.0312). Tick analyses revealed that one sample collected in Hungary was infected with <jats:italic>B. canis<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Oral administration of Bravecto chewable tablets at the recommended dosage to dogs completely prevented <jats:italic>B. canis<\/jats:italic> transmission under field conditions in an endemic area for 12\u00a0weeks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-023-05820-2","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T10:02:22Z","timestamp":1690452142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Field efficacy of fluralaner (Bravecto\u00ae chewable tablets) for preventing Babesia canis infection transmitted by Dermacentor reticulatus ticks to dogs"],"prefix":"10.1186","volume":"16","author":[{"given":"Rafael","family":"Chiummo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Zschiesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Cap\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Chiquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhimit\u00ebr","family":"Rapti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezart","family":"Postoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Audry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Leschnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"5820_CR1","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1756-3305-2-S1-S4","volume":"2","author":"PJ Irwin","year":"2009","unstructured":"Irwin PJ. Canine babesiosis: from molecular taxonomy to control. Parasit Vectors. 2009;2:S4.","journal-title":"Parasit Vectors"},{"key":"5820_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13071-016-1599-x","volume":"9","author":"G F\u00f6ldv\u00e1ri","year":"2016","unstructured":"F\u00f6ldv\u00e1ri G, \u0160irok\u00fd P, Szekeres S, Majoros G, Sprong H. Dermacentor reticulatus: a vector on the rise. Parasit Vectors. 2016;9:314.","journal-title":"Parasit Vectors"},{"key":"5820_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijpara.2018.11.007","volume":"49","author":"PJ Krause","year":"2019","unstructured":"Krause PJ. Human babesiosis. Int J Parasitol. 2019;49:165\u201374.","journal-title":"Int J Parasitol"},{"key":"5820_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2478\/acve-2020-0011","volume":"70","author":"M Leschnik","year":"2020","unstructured":"Leschnik M. Focus on common small animal vector-borne diseases in central and southeastern Europe. Acta Vet-Beograd. 2020;70:147\u201369.","journal-title":"Acta Vet-Beograd"},{"key":"5820_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/microorganisms10050945","volume":"10","author":"A Bajer","year":"2022","unstructured":"Bajer A, Beck A, Beck R, Behnke JM, Dwu\u017cnik-Szarek D, Eichenberger RM, et al. Babesiosis in Southeastern, Central and Northeastern Europe: an emerging and re-emerging tick-borne disease of humans and animals. Microorganisms. 2022;10:945.","journal-title":"Microorganisms"},{"key":"5820_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13071-016-1596-0","volume":"9","author":"L Solano-Gallego","year":"2016","unstructured":"Solano-Gallego L, Sainz \u00c1, Roura X, Estrada-Pe\u00f1a A, Mir\u00f3 G. A review of canine babesiosis: the European perspective. Parasit Vectors. 2016;9:336.","journal-title":"Parasit Vectors"},{"key":"5820_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1556\/avet.54.2006.3.7","volume":"54","author":"A Math\u00e9","year":"2006","unstructured":"Math\u00e9 A, V\u00f6r\u00f6s K, Papp L, Reiczigel J. Clinical manifestations of canine babesiosis in Hungary (63 cases). Acta Vet Hung. 2006;54:367\u201385.","journal-title":"Acta Vet Hung"},{"key":"5820_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1051\/parasite\/2014015","volume":"21","author":"L Halos","year":"2014","unstructured":"Halos L, Lebert I, Abrial D, Danlois F, Garzik K, Rodes D, et al. Questionnaire-based survey on the distribution and incidence of canine babesiosis in countries of Western Europe. Parasite. 2014;21:13.","journal-title":"Parasite"},{"key":"5820_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.vetpar.2015.05.028","volume":"211","author":"B Carcy","year":"2015","unstructured":"Carcy B, Randazzo S, Depoix D, Adaszek L, Cardoso L, Baneth G, et al. Classification of Babesia canis strains in Europe based on polymorphism of the Bc28.1\u2014gene from the Babesia canis Bc28 multigene family. Vet Parasitol. 2015;211:111\u201323.","journal-title":"Vet Parasitol"},{"key":"5820_CR10","first-page":"229","volume":"36","author":"E Schein","year":"1979","unstructured":"Schein E, Mehlhorn H, Voigt WP. Electron microscopical studies on the development of Babesia canis (Sporozoa) in the salivary glands of the vector tick Dermacentor reticulatus. Acta Trop. 1979;36:229\u201341.","journal-title":"Acta Trop"},{"key":"5820_CR11","unstructured":"Little SE. Changing paradigms in understanding transmission of canine tick-borne diseases: the role of interrupted feeding and intrastadial transmission. In: 2nd Canine Vector-Borne Disease (CVBD) Symposium. Mazara del Vallo, Sicily, Italy. 2007. p. 30\u20134."},{"key":"5820_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13071-016-1481-x","volume":"9","author":"J Taenzler","year":"2016","unstructured":"Taenzler J, Liebenberg J, Roepke RK, Heckeroth AR. Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs after topical administration of fluralaner spot-on solution. Parasit Vectors. 2016;9:234.","journal-title":"Parasit Vectors"},{"key":"5820_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13071-015-0923-1","volume":"8","author":"J Taenzler","year":"2015","unstructured":"Taenzler J, Liebenberg J, Roepke RK, Heckeroth AR. Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto\u2122). Parasit Vectors. 2015;8:305.","journal-title":"Parasit Vectors"},{"key":"5820_CR14","unstructured":"EMEA. VICH Topic GL9 (GCP). Guideline on Good Clinical Practices. The European Agency for the Evaluation of Medicinal Products (EMEA\/CVMP\/VICH\/595\/98-Final). 2000. https:\/\/www.ema.europa.eu\/en\/vich-gl9-good-clinical-practices. Accessed 5 Mar 2022."},{"key":"5820_CR15","unstructured":"European Medicines Agency. Guideline on statistical principles for veterinary clinical trials (EMA\/CVMP\/EWP\/81976\/2010). 2010. https:\/\/www.ema.europa.eu\/en\/statistical-principles-clinical-trials-veterinary-medicinal-products-pharmaceuticals#main-content. Accessed 5 Mar 2022."},{"key":"5820_CR16","unstructured":"European Medicines Agency. Demonstration of efficacy of ectoparasiticides (7AE17a). 1994. https:\/\/www.ema.europa.eu\/en\/demonstration-efficacy-ectoparasiticides. Accessed 5 Mar 2022."},{"key":"5820_CR17","unstructured":"European Medicines Agency. Guideline on data requirements for veterinary medicinal 5 products for the prevention of transmission of vector-borne diseases in dogs and cats 7 Draft. 2018. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-data-requirements-veterinary-medicinal-products-prevention-transmission-vector-borne_en.pdf. Accessed 5 Nov 2022."},{"key":"5820_CR18","unstructured":"European Medicines Agency. Bravecto (fluralaner): an overview of Bravecto and why it is authorised in the EU. https:\/\/www.ema.europa.eu\/en\/documents\/overview\/bravecto-epar-medicine-overview_en.pdf. Accessed 6 Mar 2022."},{"key":"5820_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13071-022-05242-6","volume":"15","author":"O Dan\u011bk","year":"2022","unstructured":"Dan\u011bk O, Hrazdilov\u00e1 K, Kozderkov\u00e1 D, Jirk\u016f D, Modr\u00fd D. The distribution of Dermacentor reticulatus in the Czech Republic re-assessed: citizen science approach to understanding the current distribution of the Babesia canis vector. Parasit Vectors. 2022;15:132.","journal-title":"Parasit Vectors"},{"key":"5820_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13071-021-04758-7","volume":"14","author":"D Dwu\u017cnik-Szarek","year":"2021","unstructured":"Dwu\u017cnik-Szarek D, Mierzejewska EJ, Rodo A, Go\u017adzik K, Behnke-Borowczyk J, Kiewra D, et al. Monitoring the expansion of Dermacentor reticulatus and occurrence of canine babesiosis in Poland in 2016\u20132018. Parasit Vectors. 2021;14:267.","journal-title":"Parasit Vectors"},{"key":"5820_CR21","first-page":"65","volume":"13","author":"S Casati","year":"2006","unstructured":"Casati S, Sager H, Gern L, Piffaretti JC. Presence of potentially pathogenic Babesia sp. for human in Ixodes ricinus in Switzerland. Ann Agric Environ Med. 2006;13:65\u201370.","journal-title":"Ann Agric Environ Med"},{"key":"5820_CR22","volume-title":"Synopses of the British Fauna (New Series)","author":"PD Hillyard","year":"1996","unstructured":"Hillyard PD. Ticks of north-west Europe. In: Barnes RSK, Crothers JH, editors. Synopses of the British Fauna (New Series), vol. 52. Shrewsbury: Field Studies Council; 1996."},{"key":"5820_CR23","volume-title":"Ticks of domestic animals in the Mediterranean region: a guide to identification of species","author":"A Estrada-Pe\u00f1a","year":"2004","unstructured":"Estrada-Pe\u00f1a A, Bouattour A, Camicas J-L, Walker AR. Ticks of domestic animals in the Mediterranean region: a guide to identification of species. Zaragoza: University of Zaragoza; 2004."},{"key":"5820_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.5455\/OVJ.2021.v11.i3.19","volume":"11","author":"RP Lavan","year":"2021","unstructured":"Lavan RP, Armstrong R, Newbury H, Normile D, Hubinois C. Flea and tick treatment satisfaction, preference, and adherence reported by cat owners in the US, UK, or France who treated their cats with transdermal fluralaner. Open Vet J. 2021;11:458\u201367.","journal-title":"Open Vet J"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-023-05820-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T06:02:55Z","timestamp":1700373775000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-023-05820-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5820"],"URL":"https:\/\/doi.org\/10.1186\/s13071-023-05820-2","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"assertion":[{"value":"3 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with local and national regulations. All dog owners (or delegates) were required to sign an informed consent form prior to any dog being enrolled into the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RC and EZ are employees of MSD Animal Health.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"252"}}